These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17494054)

  • 41. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups.
    Müller P; Asher N; Heled M; Cohen SB; Risch A; Rund D
    Leuk Res; 2008 Jun; 32(6):919-29. PubMed ID: 18207572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
    Rajendra R; Gounder MK; Saleem A; Schellens JH; Ross DD; Bates SE; Sinko P; Rubin EH
    Cancer Res; 2003 Jun; 63(12):3228-33. PubMed ID: 12810652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.
    Makhlouf MM; Radwan ER; Khorshed OM; Fathi LM; Elmasry MM
    Pathobiology; 2021; 88(3):211-217. PubMed ID: 33378752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
    Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of breast cancer resistance protein on cancer treatment outcomes.
    Ross DD; Nakanishi T
    Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature.
    Chen P; Zhao L; Zou P; Xu H; Lu A; Zhao P
    BMC Cancer; 2012 Sep; 12():383. PubMed ID: 22937733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
    Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
    Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
    Liu D; Wang Y; Dong M; Guan S; Wang Y; Sun H; Wu N; Li S; Bai J; Chen F; Sun D; Jin Y
    Ann Hematol; 2017 Feb; 96(2):227-235. PubMed ID: 27822610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
    Erdilyi DJ; Kámory E; Csókay B; Andrikovics H; Tordai A; Kiss C; Filni-Semsei A; Janszky I; Zalka A; Fekete G; Falus A; Kovács GT; Szalai C
    Pharmacogenomics J; 2008 Oct; 8(5):321-7. PubMed ID: 17938643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
    Hutson JR; Koren G; Matthews SG
    Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
    Andreadis C; Gimotty PA; Wahl P; Hammond R; Houldsworth J; Schuster SJ; Rebbeck TR
    Blood; 2007 Apr; 109(8):3409-16. PubMed ID: 17179223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Alteration in Hepatic and Intestinal BCRP Function In Vivo from ABCG2 c.421C>A Polymorphism Based on PBPK Analysis of Rosuvastatin.
    Futatsugi A; Toshimoto K; Yoshikado T; Sugiyama Y; Kato Y
    Drug Metab Dispos; 2018 May; 46(5):749-757. PubMed ID: 29440178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphism and transcriptional regulation of
    Zhao H; Kan Y; Wang X; Chen L; Ge P; Qian Z
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31366566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
    Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
    Nasr AS; Sami RM; Ibrahim NY
    J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.